(Q38852078)

7 September 2017

title

Putative tumor suppression function of SIRT6 in endometrial cancer (English)

1 reference

7 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

14

Yutaka Osuga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

12

Kei Kawana

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

3

Katsutoshi Oda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

4

Michihiro Tanikawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Tomohiko Fukuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Chinami Makii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Kanako Inaba

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Aki Miyasaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yuichiro Miyamoto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Tetsu Yano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Daichi Maeda

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Takeshi Sasaki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Masashi Fukayama

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Tomoyuki Fujii

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

13 July 2015

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

589

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

2274-2281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26183563%20AND%20SRC:MED&resulttype=core&format=json

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Genomic instability and aging-like phenotype in the absence of mammalian SIRT6

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

The sirtuin SIRT6 regulates lifespan in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT6 promotes DNA repair under stress by activating PARP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Human SIRT6 promotes DNA end resection through CtIP deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Endometrial cancer: a review and current management strategies: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Insulin resistance: a significant risk factor of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

PTEN1 is frequently mutated in primary endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Establishment and characterization of human endometrial cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Creation of tumorigenic human endometrial epithelial cells with intact chromosomes by introducing defined genetic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

SIRT3 positively regulates the expression of folliculogenesis- and luteinization-related genes and progesterone secretion by manipulating oxidative stress in human luteinized granulosa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Hormonal contraception and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Molecular markers of endometrial carcinoma detected in uterine aspirates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Regulation of SIRT6 protein levels by nutrient availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.043